Predilife
Predilife is dedicated to advancing preventive healthcare through predictive and personalized medical assessments. They focus on providing innovative, accessible, and cost-effective health screening services, including cancer risk assessments and multi-pathology evaluations, utilizing medical expertise, AI, and Big Data to empower individuals and organizations in health management.
Industries
Nr. of Employees
small (1-50)
Predilife
39 rue Camille Desmoulins 94805 Villejuif Cedex
Products
Colon cancer risk estimation software (user manual available)
Software-based risk estimation tool for colon cancer provided as a class I medical device; user manual available for clinical operators and users.
Melanoma risk estimation software (user manual available)
Software tool for estimating melanoma risk with associated user documentation for clinical use.
Cardiovascular risk estimation software (user manual available)
Software for estimating cardiovascular risk included in multi-pathology assessments with operator documentation.
Lung cancer risk estimation software (user manual available)
Software tool for lung cancer risk estimation with accompanying user manual.
Colon cancer risk estimation software (user manual available)
Software-based risk estimation tool for colon cancer provided as a class I medical device; user manual available for clinical operators and users.
Melanoma risk estimation software (user manual available)
Software tool for estimating melanoma risk with associated user documentation for clinical use.
Cardiovascular risk estimation software (user manual available)
Software for estimating cardiovascular risk included in multi-pathology assessments with operator documentation.
Lung cancer risk estimation software (user manual available)
Software tool for lung cancer risk estimation with accompanying user manual.
Services
Remote assessment to estimate short-term breast cancer risk and provide personalized prevention and screening recommendations via teleconsultation and an online report.
Comprehensive remote risk evaluation for multiple cancers and cardiovascular disease with personalized medical follow-up recommendations.
Remote evaluation of dietary habits, teleconsultation with a nutrition specialist, and a written report with personalized dietary recommendations.
Design and operational deployment of company-wide prevention campaigns and employee access to predictive assessments with confidentiality and program support.
Remote assessment to estimate short-term breast cancer risk and provide personalized prevention and screening recommendations via teleconsultation and an online report.
Comprehensive remote risk evaluation for multiple cancers and cardiovascular disease with personalized medical follow-up recommendations.
Remote evaluation of dietary habits, teleconsultation with a nutrition specialist, and a written report with personalized dietary recommendations.
Design and operational deployment of company-wide prevention campaigns and employee access to predictive assessments with confidentiality and program support.
Expertise Areas
- Predictive risk assessment for oncology and cardiovascular disease
- Digital telehealth platform development and deployment
- Medical device software development (Class I)
- AI-driven predictive analytics and big-data modeling
Key Technologies
- Artificial intelligence for risk prediction
- Big data analytics
- Telemedicine platform and secure patient portal
- At-home saliva sampling and genetic data integration
News & Updates
The registration for the predictive multi-pathology health assessment is now closed.
Registrations for the health check-up are now closed.
Registrations for the upcoming multi-pathology predictive assessment will open soon.
Annual campaign since 1994 to raise awareness and promote early detection of breast cancer, including company initiatives and public awareness activities.
The registration for the predictive multi-pathology health assessment is now closed.
Registrations for the health check-up are now closed.
Registrations for the upcoming multi-pathology predictive assessment will open soon.
Annual campaign since 1994 to raise awareness and promote early detection of breast cancer, including company initiatives and public awareness activities.